Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Real-world data of first-line treatment with pembrolizuma... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression in elderly patients: a subgroup analysis of HOT/NJLCG2001
0
Authors
Kazunari Tateishi
21 more
Kazunari Tateishi
•
Hidenori Mizugaki
19 more
•
Hiroshi Yokouchi
Published
December 4, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Japanese Journal of Clinical Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Surgery
Cancer
Show all topics
DOI
10.1093/jjco/hyae168
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Japanese Journal of Clinical Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Surgery
Cancer
Show all topics
DOI
10.1093/jjco/hyae168
License
CC-BY
